相似文献
1
Diagnosis and treatment of pyoderma gangrenosum.
BMJ. 2006 Jul 22;333(7560):181-4. doi: 10.1136/bmj.333.7560.181.
2
[Pyoderma gangraenosum].
Zentralbl Chir. 1996;121 Suppl:52-4.
3
Pyoderma gangrenosum: guideline for wound practitioners.
J Wound Care. 2013 Feb;22(2):68-73. doi: 10.12968/jowc.2013.22.2.68.
4
[Pyoderma gangraenosum: differential diagnosis in ulcus cruris and postoperative exacerbating processes].
Wien Med Wochenschr. 1994;144(10-11):279-80.
5
Pyoderma gangrenosum after lower extremity bypass.
Ann Vasc Surg. 2009 Nov-Dec;23(6):785.e9-11. doi: 10.1016/j.avsg.2008.08.030. Epub 2009 Jan 29.
6
Pathophysiology of pyoderma gangrenosum (PG): an updated review.
J Am Acad Dermatol. 2015 Oct;73(4):691-8. doi: 10.1016/j.jaad.2015.06.021. Epub 2015 Aug 5.
7
Pyoderma gangrenosum following breast reconstruction.
Br J Plast Surg. 2000 Jul;53(5):441-3. doi: 10.1054/bjps.2000.3349.
8
Pyoderma gangrenosum in a renal transplantation patient having immunosuppressive treatment for 5 years.
Transpl Int. 2011 Nov;24(11):e100-1. doi: 10.1111/j.1432-2277.2011.01331.x. Epub 2011 Sep 8.
9
Superficial granulomatous pyoderma: a case in an 11-year-old girl and review of the literature.
Pediatr Dermatol. 2010 Sep-Oct;27(5):496-9. doi: 10.1111/j.1525-1470.2010.01271.x.
10
Pyoderma gangrenosum following breast reconstructive surgery:a case report of treatment with immunosuppression and adjunctive xenogeneic matrix scaffolds.
J Drugs Dermatol. 2011 May;10(5):545-7.
引用本文的文献
1
Anti-IL 17 biologics and pyoderma gangrenosum - therapeutic or causal?
Arch Dermatol Res. 2025 Jan 13;317(1):235. doi: 10.1007/s00403-024-03689-4.
2
Recurrent Vegetative Pyoderma Gangrenosum of the Face: A Case Report.
Acta Med Philipp. 2024 Sep 30;58(17):74-78. doi: 10.47895/amp.v58i17.7480. eCollection 2024.
3
Pyoderma gangrenosum complicating pacemaker insertion-A rare case report.
HeartRhythm Case Rep. 2024 Jun 29;10(9):676-680. doi: 10.1016/j.hrcr.2024.06.018. eCollection 2024 Sep.
4
Management of Serious Adverse Events Following Deoxycholic Acid Injection for Submental and Jowl Fat Reduction: A Systematic Review and Management Recommendations.
Aesthet Surg J Open Forum. 2024 Aug 13;6:ojae061. doi: 10.1093/asjof/ojae061. eCollection 2024.
5
Postoperative Pyoderma Gangrenosum in a Laparoscopic Gastrectomy Port Site: A Case Report.
Juntendo Iji Zasshi. 2022 Aug 15;68(5):521-525. doi: 10.14789/jmj.JMJ22-0017-CR. eCollection 2022.
6
Empiric Treatment of Classical Pyoderma Gangrenosum in the Outpatient Setting: A Case Report.
Cureus. 2024 Jun 16;16(6):e62475. doi: 10.7759/cureus.62475. eCollection 2024 Jun.
7
Postsurgical Pyoderma Gangrenosum After Penile Inversion Vaginoplasty: Case With Review of Diagnostic and Management Strategies.
Eplasty. 2024 May 23;24:e31. eCollection 2024.
8
Episodic Presentations of Pustular Pyoderma Gangrenosum in PLHIV: A Case Report and Brief Review of Literature.
Indian J Dermatol. 2024 Mar-Apr;69(2):174-177. doi: 10.4103/ijd.ijd_680_23. Epub 2024 Apr 29.
9
From Unassuming to Unbelievable: A Case Report of Pyoderma Gangrenosum.
Cureus. 2024 Feb 3;16(2):e53491. doi: 10.7759/cureus.53491. eCollection 2024 Feb.
10
Painful Limb Ulcers: A Case Report on Ulcerative Discoid Lupus Erythematosus.
Cureus. 2024 Jan 25;16(1):e52960. doi: 10.7759/cureus.52960. eCollection 2024 Jan.
本文引用的文献
1
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.
Gut. 2006 Apr;55(4):505-9. doi: 10.1136/gut.2005.074815. Epub 2005 Sep 27.
2
Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients.
J Am Acad Dermatol. 2005 Aug;53(2):273-83. doi: 10.1016/j.jaad.2004.10.006.
3
Treatment of pyoderma gangrenosum with etanercept.
J Drugs Dermatol. 2004 Jul-Aug;3(4):441-4.
4
Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Am J Gastroenterol. 2003 Aug;98(8):1821-6. doi: 10.1111/j.1572-0241.2003.07581.x.
5
Topical tacrolimus in the management of peristomal pyoderma gangrenosum.
J Dermatolog Treat. 2001 Mar;12(1):13-7. doi: 10.1080/095466301750163518.
6
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Lancet. 2002 May 4;359(9317):1541-9. doi: 10.1016/S0140-6736(02)08512-4.
7
Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease.
Inflamm Bowel Dis. 2001 Feb;7(1):1-7. doi: 10.1097/00054725-200102000-00001.
8
The spectrum of skin disorders in abdominal stoma patients.
Br J Dermatol. 2000 Dec;143(6):1248-60. doi: 10.1046/j.1365-2133.2000.03896.x.
9
Clinical features and treatment of peristomal pyoderma gangrenosum.
JAMA. 2000 Sep 27;284(12):1546-8. doi: 10.1001/jama.284.12.1546.
10
Pyoderma gangrenosum.
Clin Dermatol. 2000 May-Jun;18(3):283-93. doi: 10.1016/s0738-081x(99)00119-4.
Zotero 插件